Ebola virus disease: A narrative review.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing existing literature without systematic review methodology or primary data.
PubMed 37355146 · doi:10.1016/j.micpath.2023.106213
What was done
This narrative review summarizes the history, epidemiology, transmission, clinical presentation, diagnosis, coinfection, and treatment landscape for Ebola virus disease, focusing on supportive care, experimental therapeutics, and vaccines.
What was found
The abstract reports no quantitative results or specific effect estimates. It highlights that early detection and supportive care (intravenous hydration, electrolyte replacement, and secondary infection management) remain the primary standard of care, while experimental monoclonal antibodies, antivirals, and vaccines show promise but require continued evaluation.
Why it matters
It provides a consolidated summary of clinical management and therapeutic developments for Ebola virus disease.
Limits
As a narrative review, it lacks a systematic search protocol, study selection criteria, risk of bias assessments, or quantitative data synthesis. No empirical numbers are provided in the abstract.
Cited by
- supports Providing proper nutrition and supportive care to patients infected with Ebola significantly increases their chances of survival.